Morphosis Capital
Overview
Morphosis Capital is a private equity firm that invests in high-growth small and medium-sized enterprises (SMEs) in Romania and the Central and Eastern European region, targeting sectors such as healthcare, B2B services, consumer products, retail, and niche manufacturing.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| EnduroSat | May 2025 | Series B | Co-investor |
| Medima Health | Oct 2022 | Private Equity | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Morphosis Capital based?
Morphosis Capital is headquartered in Bucharest, Romania.
When was Morphosis Capital founded?
Morphosis Capital was founded in 2018.
How many portfolio companies does Morphosis Capital have?
Morphosis Capital has 3 portfolio companies in Caplight's dataset.
What are some companies in Morphosis Capital's portfolio?
Portfolio companies visible on Caplight include EnduroSat, Medima Health.
What was Morphosis Capital's most recent investment shown here?
Morphosis Capital's most recent investment in this portfolio sample was in EnduroSat in 2025.
What sectors does Morphosis Capital focus on?
Morphosis Capital focuses on Consumer & Commerce, Healthcare & Life Sciences, Frontier & Industrial Tech, Telecommunications & Networking.
What company stages does Morphosis Capital focus on?
Morphosis Capital typically invests at the Early stage.
What is Morphosis Capital's AUM?
Morphosis Capital's assets under management are estimated between $194.4M and $194.4M.